Literature DB >> 1691459

Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study.

M Hiramatsu1, A K Cho.   

Abstract

The effects of (+) and (-) 3,4-methylenedioxymethamphetamine (MDMA) and racemic p-chloroamphetamine (PCA) on extracellular dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), as well as the metabolite of 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), were determined in dialysates of the striatum conscious rats by using intracerebral dialysis and high performance liquid chromatography with electrochemical detection (HPLC-EC). The (+) and (-)MDMA isomers (5, 10 mg/kg, s.c.) and PCA (2.5, 5 mg/kg, s.c.) caused a rapid increase of extracellular levels of dopamine and decreased extracellular levels of DOPAC and HVA immediately after administration in dialysates of striatum. The order of potency for this effect was PCA greater than (+)MDMA greater than (-)MDMA. The levels of 5-HIAA also decreased after the administration of drugs, but the effect had a slower time course than DOPAC and HVA and did not exhibit an enantiomeric difference. The data indicate that, although these drugs are thought to affect the 5-HT neuronal system preferentially, they also affect dopamine systems and by a mechanism in which the (+) isomer was more potent than the (-).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691459     DOI: 10.1016/0028-3908(90)90012-g

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  MDMA induced dopamine release in vivo: role of endogenous serotonin.

Authors:  S Koch; M P Galloway
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 2.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

3.  Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.

Authors:  Ryan A Gregg; Michael H Baumann; John S Partilla; Julie S Bonano; Alexandre Vouga; Christopher S Tallarida; Venkata Velvadapu; Garry R Smith; M Melissa Peet; Allen B Reitz; S Stevens Negus; Scott M Rawls
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

4.  Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.

Authors:  Daniel W Curry; Matthew B Young; Andrew N Tran; Georges E Daoud; Leonard L Howell
Journal:  Neuropharmacology       Date:  2017-10-06       Impact factor: 5.250

5.  Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.

Authors:  M I Colado; E O'Shea; R Granados; B Esteban; A B Martín; A R Green
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.

Authors:  K S Murnane; W E Fantegrossi; J R Godfrey; M L Banks; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2010-05-13       Impact factor: 4.030

7.  Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Authors:  C W Callaway; M P Johnson; L H Gold; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 8.  Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Authors:  Gary A Gudelsky; Bryan K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-10-16       Impact factor: 3.533

9.  Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.

Authors:  Julie A Suyama; Farhana Sakloth; Renata Kolanos; Richard A Glennon; Matthew F Lazenka; S Stevens Negus; Matthew L Banks
Journal:  J Pharmacol Exp Ther       Date:  2015-10-15       Impact factor: 4.030

Review 10.  (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.

Authors:  Elizabeth G Pitts; Daniel W Curry; Karly N Hampshire; Matthew B Young; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2017-12-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.